Published in Anti-Infectives Week, January 28th, 2008
"In the present study, we have investigated the interaction of another EGFR TKI, erlotinib,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Anti-Infectives Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.